Wird geladen...
Tocilizumab as a steroid sparing agent for the treatment of Graves' orbitopathy
PURPOSE: To describe the effect of tocilizumab in two patients with thyroid associated orbitopathy (TAO). OBSERVATIONS: We present two patients with TAO who could not tolerate corticosteroids and had a reduction in clinical and laboratory markers of inflammatory activity with subsequent tocilizumab...
Gespeichert in:
| Veröffentlicht in: | Am J Ophthalmol Case Rep |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722155/ https://ncbi.nlm.nih.gov/pubmed/29260102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2017.07.001 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|